Patents by Inventor Jinkui Xie

Jinkui Xie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dextran for treating lung cancer
    Patent number: 8519121
    Abstract: Dextran for preparing medicine for anti-lung cancer, has repeated structure unit and molecular weight of 1.5-2.5 million Daltons. The dextran is extracted from land slug.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: August 27, 2013
    Assignee: Guangzhou Konzern Pharmaceutical Co., Ltd.
    Inventors: Jinkui Xie, Anqiang Zhang, Jianguo Cao
  • DEXTRAN FOR TREATING LUNG CANCER
    Publication number: 20110263842
    Abstract: Dextran for preparing medicine for anti-lung cancer, has repeated structure unit and molecular weight of 1.5-2.5 million Daltons. The dextran is extracted from land slug.
    Type: Application
    Filed: June 23, 2008
    Publication date: October 27, 2011
    Applicant: Guangzhou Kanzem Pharmaceuticla Co., Ltd.
    Inventors: Jinkui Xie, Anqiang Zhang, Jianguo Cao
  • GLYCOPROTEIN FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES
    Publication number: 20100048457
    Abstract: Provided is a glycoprotein product extracted from limax, wherein the preparation method of the glycoprotein product comprises the following steps: adding ethanol to the dry limax powders and removing the supernatant, extracting the resulting residue with water and then adding ethanol to the water extract for precipitating. The obtained glycoprotein product can be used for treating chronic obstructive pulmonary diseases (COPD) and has antibacterial and antiphlogistic effects.
    Type: Application
    Filed: January 17, 2008
    Publication date: February 25, 2010
    Applicant: Guangzhou Konzern Pharmacetuical Co. Ltd
    Inventor: Jinkui Xie
  • COMPOSITION AND METHOD FOR WEIGHT LOSS
    Publication number: 20090169490
    Abstract: A weight loss composition consisting of 1 to 10 weight parts of L-hydroxy citric acid and 1 to 10 weight parts of L-carnitine tartrate as active components, and pharmaceutically or food-acceptable carrier is disclosed. The present composition can be made to tablet, capsule, oral juice or chewing gum which shows great effect of weight loss.
    Type: Application
    Filed: December 23, 2008
    Publication date: July 2, 2009
    Inventors: Jinkui Xie, Minhua Liu